How ischaemic preconditioning protects small liver grafts

Area of Science:

• Hepatology
• Transplantation Immunology
• Molecular Biology

Background:

• Interleukin-1 (IL-1) and transforming growth factor-beta (TGFbeta) inhibit hepatocyte proliferation post-hepatectomy.
• Heat shock proteins (HSPs) can inhibit IL-1 during inflammation.
• Ischaemic preconditioning shows promise in reduced-size orthotopic liver transplantation (ROLT).

Purpose of the Study:

• To investigate ischaemic preconditioning's effect on IL-1 and TGFbeta in ROLT.
• To determine if preconditioning protects small liver grafts via HSP induction.
• To explore the link between preconditioning-induced HSPs and IL-1 inhibition.

Main Methods:

• Utilized an IL-1 receptor antagonist to assess IL-1's role in ischaemia-reperfusion (I/R) injury.
• Examined the impact of preconditioning on IL-1, TGFbeta, HSPs, and nitric oxide (NO) pathways.
• Evaluated the effects of HSP70 and haem-oxygenase-1 (HO-1) on liver regeneration and I/R injury.

Main Results:

• IL-1 was found to injure grafts, reduce hepatocyte growth factor (HGF), and increase TGFbeta, impairing regeneration in ROLT.
• Preconditioning inhibited IL-1 via nitric oxide (NO) and, independently, induced HSP70 and HO-1.
• HO-1 mitigated I/R injury and aided regeneration, while HSP70 primarily benefited hepatocyte proliferation.

Conclusions:

• Preconditioning protects small liver grafts by modulating IL-1 and inducing HSPs, offering a mechanism for improved ROLT outcomes.
• Targeting IL-1 and/or HSPs presents potential clinical strategies for enhancing liver regeneration, especially in small graft scenarios.